Pretransplant donor-specific HLA class-I and -II antibodies are associated with an increased risk for kidney graft failure

American Journal of Transplantation

Volumn 12, Issue 6, 2012, Pages 1618-1623

  Otten, H G ^a   Verhaar, M C ^b   Borst, H P E ^a   Hene R J ^b,c   Zuilen, A D Van ^b  

^a Departments of Immunology   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c Dianet Foundation   (Netherlands)

Author keywords

C1q; donor specific antibodies; kidney transplantation; single antigen bead array

Indexed keywords

COMPLEMENT COMPONENT C1Q; CYCLOSPORIN; HLA ANTIBODY; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN G; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; ANTIBODY SPECIFICITY; ARTICLE; FEMALE; FLUORESCENCE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT FAILURE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR;

GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; KIDNEY TRANSPLANTATION; RISK FACTORS;

EID: 84861816090     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03985.x     Document Type: Article

References (15)

1. Patel R, Terasaki PI,. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969; 280: 735-737.
2. El-Awar N, Lee J, Terasaki PI,. HLA antibody identification with single antigen beads compared to conventional methods. Hum Immunol 2005; 66: 989-997.
3. Eng HS, Bennett G, Tsiopelas E, et al,. Anti-HLA donor-specific antibodies detected in positive B-cell crossmatches by Luminex predict late graft loss. Am J Transplant 2008; 8: 2335-2342.
4. Singh N, Djamali A, Lorentzen D, et al,. Pretransplant donor-specific antibodies detected by single-antigen bead flow cytometry are associated with inferior kidney transplant outcomes. Transplantation 2010; 90: 1079-1084.
5. Riethmüller S, Ferrari-Lacraz S, Müller MK, et al,. Donor-specific antibody levels and three generations of crossmatches to predict antibody-mediated rejection in kidney transplantation. Transplantation 2010; 90: 160-167.
6. Lefaucheur C, Loupy A, Hill GS, et al,. Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. J Am Soc Nephrol 2010; 21: 1398-1406.
7. Süsal C, Ovens J, Mahmoud K, et al,. No association of kidney graft loss with human leukocyte antigen antibodies detected exclusively by sensitive Luminex single-antigen testing: A Collaborative Transplant Study report. Transplantation 2011; 91: 883-887.
8. Amico P, Hönger G, Mayr M, Steiger J, Hopfer H, Schaub S,. Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads. Transplantation 2009; 87: 1681-1688.
9. Chin C, Chen G, Sequeria F, et al,. Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients. J Heart Lung Transplant 2011; 30: 158-163.
10. Chen G, Sequeira F, Tyan DB,. Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads. Hum Immunol 2011; 72: 849-858.
11. Rood JJ van, van Leeuwen A, Ploem JS,. Simultaneous detection of two cell populations by two-colour fluorescence and application to the recognition of B-cell determinants. Nature 1976; 262: 795-797.
12. Yabu JM, Higgins JP, Chen G, Sequeira F, Busque S, Tyan DB,. C1q-fixing human leukocyte antigen antibodies are specific for predicting transplant glomerulopathy and late graft failure after kidney transplantation. Transplantation 2011; 91: 342-347.
13. Roos A, Ramwadhdoebé TH, Nauta AJ, Hack CE, Daha MR,. Therapeutic inhibition of the early phase of complement activation. Immunobiology 2002; 205: 595-609.
14. Lefaucheur C, Antoine C, Suberbielle C, Glotz D,. Mastering the risk of HLA antibodies in kidney transplantation: An algorithm based on pretransplant single-antigen flow bead techniques. Am J Transplant 2011; 11: 1592-1598.
15. Bächler K, Amico P, Hönger G, et al,. Efficacy of induction therapy with ATG and intravenous immunoglobulins in patients with low-level donor-specific HLA-antibodies. Am J Transplant 2010; 10: 1254-1262.